Literature DB >> 30053560

C2-C3 Anterior Cervical Arthrodesis in the Treatment of Bow Hunter's Syndrome: Case Report and Review of the Literature.

Victoria Schunemann1, Jeeho Kim1, David Dornbos1, Shahid M Nimjee2.   

Abstract

BACKGROUND: Bow hunter's syndrome (BHS) or rotational vertebral artery occlusion is a rare syndrome of vertebrobasilar insufficiency due to compression or occlusion of the contralateral vertebral artery with cervical axial rotation. Compression at the C2-C3 level, the junction between the axial and subaxial spine, has not been described. Management can include medical treatment with antiplatelet medications, surgical fusion, or vertebral artery decompression. CASE DESCRIPTION: The patient presented with dizziness and loss of consciousness with axial head rotation to the left. Dynamic digital subtraction angiography revealed occlusion of the right vertebral artery with the head turning to the left, with concurrent symptom onset. The left vertebral artery largely ended in the posterior inferior cerebellar artery. The patient underwent C2-C3 anterior cervical discectomy and fusion without vertebral artery decompression. His postoperative course was uneventful, with complete symptom resolution. Follow-up dynamic angiography demonstrated a patent right vertebral artery with axial head rotation to the left.
CONCLUSIONS: This case report demonstrates that even high cervical etiology for BHS can be successfully managed from an anterior approach. At present, no consensus has been reached for the treatment of BHS. A review of the current data demonstrated that anterior approaches without decompression are slightly safer than posterior approaches, with a smaller risk of vertebral artery injury. Depending on the anatomic variant and the pathophysiology of vertebral compression, an anterior approach without decompression provides a feasible alternative for the treatment of symptomatic BHS.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ACDF; Anterior cervical discectomy and fusion; Bow hunter's syndrome; Rotational vertebral artery occlusion

Mesh:

Year:  2018        PMID: 30053560     DOI: 10.1016/j.wneu.2018.07.129

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  7 in total

1.  Bow hunter's syndrome successfully treated with a posterior surgical decompression approach: A case report and review of literature.

Authors:  Niccolò Orlandi; Francesco Cavallieri; Ilaria Grisendi; Antonio Romano; Reza Ghadirpour; Manuela Napoli; Claudio Moratti; Matteo Zanichelli; Rosario Pascarella; Franco Valzania; Marialuisa Zedde
Journal:  World J Clin Cases       Date:  2022-05-16       Impact factor: 1.534

2.  Bow hunter syndrome in rheumatoid arthritis: illustrative case.

Authors:  Brian P Curry; Vijay M Ravindra; Jason H Boulter; Chris J Neal; Daniel S Ikeda
Journal:  J Neurosurg Case Lessons       Date:  2021-07-19

Review 3.  Rotational vertebral artery occlusion ("bow hunter syndrome").

Authors:  Ronald Schulz; Rodrigo Donoso; Karen Weissman
Journal:  Eur Spine J       Date:  2021-01-02       Impact factor: 3.134

4.  Fusion for subaxial bow hunter's syndrome results in remote osseous remodeling of the hyperostotic growth responsible for vertebral artery compression.

Authors:  Daniel Satoshi Ikeda; Charles A Miller; Vijay M Ravindra
Journal:  Surg Neurol Int       Date:  2021-03-17

5.  Ischemic Stroke Secondary to Dynamic Vertebral Artery Stenosis: Case Report and Review of the Literature.

Authors:  Mohammed K Bukhari; Saeed A Alghamdi
Journal:  Cureus       Date:  2021-12-04

6.  A Surgical Case of Bow Hunter's Syndrome Diagnosed by Cervical Rotational MRA.

Authors:  Hidenori Matsuoka; So Ohashi; Michihisa Narikiyo; Ryo Nogami; Keita Hashimoto; Hirokazu Nagasaki; Yoshifumi Tsuboi
Journal:  Case Rep Orthop       Date:  2022-08-04

Review 7.  Clinical Importance of the Posterior Inferior Cerebellar Artery: A Review of the Literature.

Authors:  Hui-Lei Miao; Deng-Yan Zhang; Tao Wang; Xiao-Tian Jiao; Li-Qun Jiao
Journal:  Int J Med Sci       Date:  2020-10-18       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.